Copy of Newspaper Publication

ARROW GREENTECH LTD November 6, 2026 Manager (CRD) Manager (CRD) BSE Ltd. National Stock Exchange of India Ltd. (NSE) P.J. Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex Mumbai 400 001 Bandra (E), Mumbai - 400051 Ref: Script Code- 516064 Script Code- ARROWGREEN Sub: Newspaper Advertisement- Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above captioned subject, please find enclosed newspaper advertisement published in The Economic Times and Mumbai Lakshadeep on Friday, November 06, 2026, containing extract of Unaudited Financial Results for the quarter/ half year ended September 30, 2026. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Arrow Greentech Limited Poonam Bansal Company Secretary ARROW GREENTECH LTD CIN No.: L21010MH1992PLC069281 Registered Office: 1/F Laxmi Industrial Estate, New Link Road, Andheri (West), Mumbai 400 053, Maharashtra, Phone: +91 22-4974 3758 , Email : contact@arrowgreentech.com Website: www.arrowgreentech com Works: Plot No 531 0,5311, GIDC, Ankleshwar 392002, Gujarat, INDIA Phone : +912646-224743/224744 E-mail : ank@arrowgreentech.com Companies: Pursuit of Profit (cid:31)19 THE ECONOMIC TIMES | MUMBAI | FRIDAY | 6 NOVEMBER 2026 | WWW.ECONOMICTIMES.COM Mehli Mistry Challenges Removal From Tata Trusts urging the authority to reject the change Contests objections, says report as “illegal, non-est and contrary to the Trust Deed”. His principal argument eligibility criteria should is that neither the 1913 Will nor the 1923 Trust Deed prescribes a fixed tenure for apply equally to Noel Tata trustees. He contends that the trust’s po- sition that his three-year term had expi- red relies on a 2022 circular and appoint- Our Bureau ment letter, neither of which can overri- de the governing instruments. Mumbai: Former Tata trustee Mehli Citing Clause 23 of the Deed, Mistry po- Mistry has challenged his removal from inted out that vacancies arise on grounds the Bai Hirabai Jamsetji Tata Navsari including death, permanent residence Charitable Institution (BHJTNCI), tel- outside the Bombay Presidency, insol- ling the deputy charity commissioner, vency, renunciation of faith and unfit- Greater Mumbai Region, that the deci- ness, but not on expiry of a fixed term. sion was illegal and that the trustees who He has also relied on the Codicil’s direc- voted against his reappointment were tion that trustees “shall always be the themselves ineligible. In a series of rejo- Trustees”. He argued that he is not a “te- inders filed before the authority, Mistry nure trustee” under Section 2(17A), intro- has questioned the eligibility of Noel Ta- zen, a UAE tax resident and a UAE Golden duced through the 2025 amendment, and ta and other trustees, challenged the vali- Visa holder. He has sought an affidavit that Section 30A(1) therefore does not dity of voting resolutions and accused from Tata detailing his apply to him. He has also cited the trust’s the Sir Dorabji Tata Trust (SDTT) of at- citizenship and tax resi- annexures, which allegedly show diffe- tempting to prevent scrutiny of alleged Mistry alleged dency history, including rent renewal periods for other trustees, governance lapses, including commis- that Tata is an whether he has held a including about two years for Vijay Singh sions and financial benefits received by Irish citizen, a Swiss passport. and less than two years for Venu Sriniva- trustees. The matter has been adjourned UAE tax He has also questioned san. “The Trust cannot use Section 30A to December 3. resident and a whether Tata practises (1) as a sword to oust the Objector on 28 In a 24-page rejoinder filed under Sec- UAE Golden the Zoroastrian faith October 2025 and, in the same breath, ig- tion 22 of the Maharashtra Public Trusts Visa holder. He and sought affidavits nore that very provision when its own Vi- Act, 1950, Mistry has contested the trust’s has sought an from all trustees on the- ce Chairman acted in breach of it on that objections to his citizenship and tax resi- affidavit from ir eligibility under the very day. A party cannot approbate and dency. He argued that neither the Will, Tata detailing Trust Deed. reprobate,” the submission states. Codicil nor Trust Deed prescribes citi- his citizenship “If foreign citizenship Mistry has also relied on a resolution zenship or tax residency as a qualifica- and overseas residence passed on October 17, 2024, at a joint mee- tion for trusteeship. are to be treated as relevant considera- ting of SDTT and Sir Ratan Tata Trust While asserting that he is a Parsi Zoro- tions, they must be examined in relation trustees, shortly after Ratan Tata’s de- astrian with a residence in Colaba, he ar- to the Reporting Trustee with equal rigo- ath. He claimed the resolution provided gued that any such eligibility criteria ur,” the rejoinder states. for trustees to be reappointed on expiry must apply equally to Noel Tata, the cur- Mistry has separately challenged the re- of their terms without any limit on tenu- rent reporting trustee. cording of his cessation as a BHJTNCI re and alleged that the trust deliberately Mistry alleged that Tata is an Irish citi- trustee with effect from October 28, 2025, omitted it from its reply. US FDA Flags Data Integrity Lapses at Indian Drug Facilities Inspections find cases where FFDDAA’’ss KKeeyy CCiittaattiioonnss critical documents discarded Procedures not Computer in writing, or control of master or destroyed, says official fully followed formula records Investigations Cleaning/sanitising/ Vikas Dandekar of discrepancies, maintenance procedures and Rica Bhattacharyya failures for sterile drug products Mumbai:The US Food and Drug Admi- Scientifi cally Control procedures to nistration (FDA) continues to find serio- ssoouunndd llaabboorraattoorryy monitor and validate us data-integrity violations at Indian ccoonnttrroollss performance pharmaceutical manufacturing faciliti- es and clinical research organisations, making information they submit for re- building reliable and resilient supply this level, whether they are vendors, gulatory assessment unacceptable, a se- chains. contractors or even companies operating nior agency official said. FDA inspections continue to identify in your community, do not look the other Eight years after FDA issued guidelines unacceptable and, in some cases, gross way.” She was speaking at the 25th anni- on data integrity, its inspectors continue insanitary conditions in manufacturing versary of the Pharmaceutical Analysts to find violations that require the affec- facilities, she said, sharing pictures of Convention of Indian Drug Manufactu- ted studies or tests to be repeated for reli- dirty facilities. rers Association. able data, Constance Richard-Math, the Richard-Math urged drugmakers to lo- During FY2025, the US FDA issued 39 agency’s deputy country director in In- ok beyond their own facilities and scruti- OAI (official action indicated), which dia, told an industry gathering in Mum- nise suppliers, vendors and other entiti- may include warning letters. While 149 bai. FDA’s routine or unannounced in- es across the supply chain to ensure the inspections required voluntary action, spections have also uncovered cases in safety of medicines. 53 drew no regulatory action from the which truckloads of key documents rela- “These may not be your facilities, but I agency. ting to analytical testing, manufacturing would ask you to look beyond the walls of To build a robust culture of compliance, procedures and storage were discarded, your own facilities: know your suppliers, Richard-Math advised companies to de- including records destroyed using paper know your vendors, know who is opera- tect warning signs early and resolve issu- shredders, Richard-Math said. ting within your supply chain,” she said. es before they cause product failures, re- These violations, she warned, impedes “If you identify facilities ope [Showing first 8,000 characters — download PDF for full document]